Results 221 to 230 of about 22,239 (295)

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.

JAMA Netw Open
Chung MC, Yu TM, Wu LY, Wu MJ, Shieh JJ, Chung CJ.   +5 more
europepmc   +1 more source

Cardioprotective glucose-lowering drugs, statins, and risk of first-time atherosclerotic cardiovascular disease in Denmark: a nationwide cohort study. [PDF]

Lancet Reg Health Eur
Ternhamar T, Johansen MØ, Nordestgaard BG, Afzal S.   +3 more
europepmc   +1 more source

SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study. [PDF]

Diabetes Obes Metab
Azegami T, Kaneko H, Okada A, Suzuki Y, Ko T, Aoyama K, Nakayama T, Kimura Y, Fujiu K, Takeda N, Morita H, Yokoo T, Node K, Nangaku M, Takeda N, Yasunaga H, Hayashi K.   +16 more
europepmc   +1 more source

Association of <i>DPP4</i> Gene Variants with Classic and DPP4 Inhibitor-Associated Bullous Pemphigoid. [PDF]

Int J Mol Sci
Achilla C, Foutsitzidou C, Meltzanidou P, Patsatsi A, Lazaridou E, Tzatzagou G, Lambropoulos A, Chatzikyriakidou A.   +7 more
europepmc   +1 more source

Cancer risk associated with DPP4 inhibitors in type 2 diabetes: A pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS). [PDF]

PLoS One
Xiong W, Li Y, Huang J, He G, Sun J.
europepmc   +1 more source

Concomitant Use of DPP-4 Inhibitors May Prevent the Development of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Cohort Study. [PDF]

Clin Transl Sci
Koura Y, Mine K, Fujita S, Kawashiri T, Mori Y, Ueda M, Kaneko R, Hirota T, Uchida M, Kobayashi D.   +9 more
europepmc   +1 more source

Peptides From Adzuki Bean and Soybean Improved Insulin-AKT Signaling-Related Pathways in Healthy and Insulin-Resistant States in Human Liver Cells. [PDF]

Mol Nutr Food Res
Kwan SH, Gonzalez de Mejia E.
europepmc   +1 more source

SGLT2 inhibitors, GLP-1 RAs, and DPP4 inhibitors and the risk of hypomagnesemia in type 2 diabetes: A target trial emulation. [PDF]

PLoS Med
Shao SC, Tsai DH, Chuang AT, Liu KH, Lai EC.   +4 more
europepmc   +1 more source

Combined effects of physical activity and diabetes medications on glycemic control: a real-world data study. [PDF]

Sci Rep
Yamamoto K, Kai R, Inano A, Mizuno M.
europepmc   +1 more source

Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus. [PDF]

Pharmacoepidemiol Drug Saf
Aloke C, Adelusi OA, Onisuru OO, Iwuchukwu EA, Achilonu I.   +4 more
europepmc   +1 more source